Form 4: Moderna's Chief Legal Officer Shannon Thyme Klinger Reports Stock Transactions
SEC Form 4 Filing
Chief Legal Officer of Moderna, Shannon Thyme Klinger, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On March 7, 2024, Shannon Thyme Klinger, Chief Legal Officer of Moderna, Inc., had restricted stock units convert into 1,138 shares of common stock.
- Also on March 7, 2024, Klinger disposed of 9,811 shares.
- On March 8, 2024, Klinger sold 544 shares of common stock at a price of $99.0509 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Klinger directly owns 9,267 shares of Moderna common stock and 5,694 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares, but the overall impact is likely minimal as it is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| June 7, 2022 | 25% of the shares subject to the restricted stock unit award vested. |
| March 7, 2024 | Restricted stock units converted into common stock. |
| March 8, 2024 | Shares sold to cover tax withholding obligations. |
| March 11, 2024 | Date of the signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.